Rybrevant sales 2023 million?

What were Rybrevant (amivantamab) sales in 2023?

Rybrevant sales in 2023 were reported as about $1.28 million. [1]

Is the “$1.28 million” figure for global sales or a specific market?

The provided figure is sourced from DrugPatentWatch’s sales estimate for 2023, but the source doesn’t specify in the snippet you provided whether it’s global or tied to a particular geography. For the most accurate context, check the same DrugPatentWatch page entry that reports the 2023 sales number. [1]

Where can I verify Rybrevant 2023 sales and track updates?

You can verify the latest sales estimates and any updates on the Rybrevant drug page at DrugPatentWatch.com. [1]

Sources:
1